<bill session="111" type="h" number="4956" updated="2023-01-11T13:16:21Z">
  <state datetime="2010-03-25">REFERRED</state>
  <status>
    <introduced datetime="2010-03-25"/>
  </status>
  <introduced datetime="2010-03-25"/>
  <titles>
    <title type="display">Stop Oxy Abuse Act of 2010</title>
    <title type="official" as="introduced">To direct the Commissioner of Food and Drugs to modify the approval of any drug containing controlled-release oxycodone hydrochloride to limit such approval to use for the relief of severe-only instead of moderate-to-severe pain, and for other purposes.</title>
    <title type="short" as="introduced">Stop Oxy Abuse Act of 2010</title>
  </titles>
  <sponsor bioguide_id="B001228"/>
  <cosponsors>
    <cosponsor bioguide_id="B001260" joined="2010-05-18"/>
    <cosponsor bioguide_id="D000210" joined="2010-05-18"/>
    <cosponsor bioguide_id="D000533" joined="2010-03-25"/>
    <cosponsor bioguide_id="K000360" joined="2010-05-18"/>
    <cosponsor bioguide_id="L000562" joined="2010-03-25"/>
    <cosponsor bioguide_id="M001155" joined="2010-03-25"/>
    <cosponsor bioguide_id="R000395" joined="2010-03-25"/>
    <cosponsor bioguide_id="T000459" joined="2010-03-25"/>
    <cosponsor bioguide_id="W000413" joined="2010-03-25"/>
    <cosponsor bioguide_id="W000672" joined="2010-04-14"/>
  </cosponsors>
  <actions>
    <action datetime="2010-03-25">
      <text>Introduced in House</text>
    </action>
    <action datetime="2010-03-25" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2010-05-20T20:16:18Z" status="Introduced in House">Stop Oxy Abuse Act of 2010 - Directs the Commissioner of Food and Drugs (FDA), within 90 days, to take such actions as may be necessary to modify the approval of, and limit any subsequent approval of, any drug containing controlled-release oxycodone hychloride to use for the relief of severe-only pain instead of moderate-to-severe pain.

Applies any such modification to drugs introduced into interstate commerce 180 days after enactment of this Act.</summary>
</bill>
